Regular Prospera testing helps minimize the risk of Mike’s unique clinical factors leading to transplant rejection

Regular Prospera testing helps minimize the risk of John’s unique clinical factors leading to transplant rejection

Regular Prospera testing helps minimize the risk of Mary’s unique clinical factors leading to transplant rejection

Anti-rejection therapies in renal transplant patients may influence total cell-free DNA, impacting the relative quantification of donorderiv

Become part of the community helping to address immunotherapy cancer care

BESPOKE study of ctDNA guided immunotherapy (IO)

Discontinuing immunotherapy treatment due to prolonged, durable complete response

Early tumor progression during first-line immunotherapy treatment

Indeterminate imaging during immunotherapy treatment

Bespoke study of ctDNA guided immunotherapy

Empower Patient Brochure

Prospera Kidney General Nephrology Brochure

Prospera is powered by highly optimized, proprietary cell-free DNA (cfDNA) technology. As part of your tool kit, Prospera assesses all types of kidney transplant rejection with great precision.

Prospera Kidney Transplant Provider Brochure

Prospera assesses all types of kidney transplant rejection with great precision.

Anora Patient Brochure

Find the answers you’re looking for after a miscarriage.